http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1020530-A4
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b9036c33bbe3f4ea428655b76200f7c |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-07 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-62 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P7-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-06 |
| filingDate | 1998-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c5c208af31699543191837fc763a929 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c614af1f02b7c850d0d0f68a54fd31e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbfc284601b0bde18c4b2b0ad2ed07c8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0f4627a9e8b740e1b9fc2291fe5b1f1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc5ceabb4ecdd50303bada2fb441919a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47a6a02b67d79c311bd43cc08479a383 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_857e09db4f7c3d99db22e357531c0b7a |
| publicationDate | 2003-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1020530-A4 |
| titleOfInvention | PREPARATION OF HMG-CoA REDUCTASE INHIBITORS |
| abstract | Disclosed is a process for producing a compound represented by general formula (II-a): <CHEM> (wherein R<1> represents a hydrogen atom, a substituted or unsubstituted alkyl group, or an alkali metal; and R<2> represents a substituted or unsubstituted alkyl or aryl group) Ähereinafter referred to as Compound (II-a)Ü or the lactone form of Compound (II-a) Ähereinafter referred to as Compound (II-b)Ü which comprises subjecting a compound represented by general formula (I-a): <CHEM> (wherein R<1> represents a hydrogen atom, a substituted or unsubstituted alkyl group, or an alkali metal; and R<2> represents a substituted or unsubstituted alkyl or aryl group) Ähereinafter referred to as Compound (I-a)Ü or the lactone form of Compound (I-a) Ähereinafter referred to as Compound (I-b)Ü to the action of an enzyme source derived from a microorganism belonging to the genus Bacillus and capable of converting Compound (I-a) or Compound (I-b) into Compound (II-a) or Compound (II-b) in a reaction mixture to form Compound (II-a) or Compound (II-b) in the reaction mixture, and recovering Compound (II-a) or Compound (II-b) from the reaction mixture. |
| priorityDate | 1997-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.